Company overview:
1910 Genetics is the only company that has built a synergistic,
dual-purpose small and large molecule platform that integrates artificial intelligence (AI),
computation, and biological automation to design drug-like molecules better, faster, and cheaper than traditional approaches.
Based in the Seaport District of Boston, 1910 Genetics is a Series A stage biotechnology startup that was founded in 2018
and is backed by prestigious investors, including M12-Microsoft’s Venture Fund, Sam Altman – the CEO of OpenAI (makers of ChatGPT),
Playground Global, Y Combinator, New Ventures Funds (Scientia Ventures), and many others.
At 1910 Genetics, we first established an understanding of the molecular basis of disease to the granularity at
which the world understands sickle cell anemia. This understanding centers biology as our North Star and drives
our integration of artificial intelligence (AI), computation, and biological automation to accelerate the design
of small molecule and protein therapeutics.
Recent advances in computational technologies have placed historically
“undruggable” targets within therapeutic reach. But at 1910 Genetics,
we often say “Biology is King,” meaning that computational technologies
are only impactful in drug discovery when driven by experimental biology.
Our platforms’ scale and breadth empower us to be therapeutic area-agnostic
with programs ranging from neuroscience and immunology to infectious disease
and oncology, to name a few.
COMPANY OVERVIEW
Computation is revolutionizing drug discovery. Advances in big chemical data, massive computing power, artificial intelligence, and molecular dynamics simulation are changing the way we develop new drugs. At 1910 Genetics, we put computation at the heart of drug discovery, blending expertise in computational chemistry, structural biology, pharmacology, genetics, data science, and software engineering to develop drugs for previously undruggable targets.
The Sr./Exec. Director of Business Development at 1910 Genetics will be an important member of the team to drive our partnering strategy. Based in the United States, you will be a part of a team who is passionate about the transforming experience that AI can bring to drug discovery.
Essential Job Functions:
- Collect market, business and technical information to develop business insights on partners and competitors.
- Responsible for scouting key partners/customers, contacts and manage out-reach as well as in-bound reach to secure face to face meetings for formal sales pitch presentation
- Assist CEO and CBO on key conferences management, build and adapt the sales pitch, to drive sales strategies, non-confidentiality discussions and deal execution
- Maintain meticulous sales pipeline (CRM), and meeting records to provide timely updates to senior management.
- Negotiate Term-sheet, manage Due Diligence process to get the right expertise needed.
- Able to travel 20% to 40% of the time
Qualifications:
- PhD a must with an undergraduate degree in biology, medicinal chemistry related field
- 7-10 years in early drug discovery and development process,
- 3-5 years of successful search and evaluation business development track record
- A solid out-licensing, collaboration and/or service deal track record is required with industry rolodex.
- Excellent verbal and written communication skills, including fluency in English.
- Hard working, energetic, flexible, agile and ability to learn on the fly.
- Willing to adapt to a fast-paced working environment with a sense of urgency.
- Strong people skills. A strong team player who is willing to mentor other junior members.
- Able to work independently. A great team player and able to work in a diverse, multicultural, and globally distributed team.
Compensation & benefits
- Competitive salary
- Once in a lifetime opportunity to help scale a fast growth, VC-backed startup at the intersection of technology and life sciences
- Super cool team building activities
- Flexible work schedule
- Great colleagues